Cramer: Buy Vistra, Even as It’s a Falling Knife
TL;DR Summary
In Mad Money’s Lightning Round, Jim Cramer says Vistra has pulled back after a run-up and labels it a falling knife, but would still buy with a cautious 25% position; he also weighs in on FICO, Clover Health, and Stryker.
Reading Insights
Total Reads
0
Unique Readers
23
Time Saved
2 min
vs 2 min read
Condensed
88%
343 → 40 words
Want the full story? Read the original article
Read on CNBC